Showing results (1041-1050 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|June 12, 2026
Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-AnalysisAndrew J Cutler, Anaïs Lemyre, Qiaoyi Zhang, et al.
Advances in Therapy|June 6, 1996
Beclomethasone dipropionate given to adult asthmatics through a new spacer device: effects of high-dose administrationG Girbino, G Lauriello, F Andó, et al.
Advances in Therapy|August 10, 2020
Angiotensin-Converting Enzyme Inhibition: Beyond Blood Pressure Control-The Role of ZofenoprilClaudio Borghi, Stefano Omboni
Advances in Therapy|June 17, 2026
Evaluating the Complementary Nature of Randomized Controlled Trials and Real-World Evidence Using Over 5 Years of Experience with Fremanezumab: A Narrative ReviewPiero Barbanti, Timothy Smith, Verena Ramirez Campos, et al.
Advances in Therapy|July 27, 2018
Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot TrialNorbert J Tripolt, Slaven Stekovic, Felix Aberer, et al.
Advances in Therapy|August 28, 2012
SWAAT study: extracorporeal shock wave therapy and arginine supplementation and other nutraceuticals for insertional Achilles tendinopathyAngela Notarnicola, Vito Pesce, Giovanni Vicenti, et al.
Advances in Therapy|January 29, 2024
Artificial Intelligence in Liver Diseases: Recent AdvancesFeifei Lu, Yao Meng, Xiaoting Song, et al.
Advances in Therapy|July 13, 2026
Post Hoc Subgroup and Body Region Analyses of VASI Outcomes Among Patients with Vitiligo in a Phase 2 Povorcitinib TrialThierry Passeron, Amit G Pandya, Khaled Ezzedine, et al.
Advances in Therapy|June 30, 2026
Management of Persistent Storage Symptoms and Overactive Bladder in Men Diagnosed with Benign Prostatic Hyperplasia: A Narrative ReviewBradley C Gill, Matt T Rosenberg, Steven A Kaplan, et al.
Advances in Therapy|June 30, 2026
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE StudyGiuseppe Privitera, Flavia Palumbo, Fabio Salvatore Macaluso, et al.
Pageof 457